Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 11, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Developments in external beam radiotherapy for prostate cancer.

Nicolaas Lumen1, Piet Ost, Charles Van Praet

  • 1Department of Urology, Ghent University Hospital, Ghent, Belgium.

Urology
|May 28, 2013
PubMed
Summary

External beam radiotherapy (EBRT) is a key treatment for radiosensitive prostate cancer (PC). This review covers current, recent, and emerging indications for EBRT in PC management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating MRI-based tumour staging within the TNM classification system in modern prostate cancer management.

Insights into imaging·2026
Same author

ProBIOPSY: A Multidisciplinary International Consensus on Standards for Prostate Biopsy.

European urology·2026
Same author

Correction: Measurement of renal tumor size: the impact of 2D versus 3D methods on the T-stage.

Abdominal radiology (New York)·2026
Same author

A step-by-step guide for implementation of virtual surgical applications and patient data centralization: practical experience and lessons learned.

3D printing in medicine·2026
Same author

Incidence and impact of pseudoprogression and mixed responses in metastatic renal cell carcinoma patients treated with ipilimumab/nivolumab: a retrospective analysis.

Acta oncologica (Stockholm, Sweden)·2026
Same author

Oligometastatic prostate cancer - bridging the gap between localized and metastatic disease.

Nature reviews. Urology·2026

Area of Science:

  • Oncology
  • Radiation Oncology

Background:

  • Prostate cancer (PC) is a radiosensitive malignancy.
  • External beam radiotherapy (EBRT) is an established treatment modality for PC.

Purpose of the Study:

  • To provide an overview of current indications for EBRT in prostate cancer.
  • To discuss recent advancements in EBRT techniques for PC.
  • To highlight novel and promising future applications of EBRT in PC treatment.

Main Methods:

  • Literature review of current and emerging EBRT applications in prostate cancer.
  • Analysis of recent developments in radiotherapy technology and clinical trials.
  • Synthesis of evidence for established and potential indications.

Main Results:

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Related Experiment Videos

Last Updated: May 11, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

  • EBRT is a well-established treatment for various stages of prostate cancer.
  • Recent developments include advanced planning and delivery techniques improving precision.
  • Emerging indications show potential for improved outcomes in specific patient subgroups.

Conclusions:

  • EBRT remains a cornerstone in prostate cancer management.
  • Technological advancements continue to refine EBRT efficacy and safety.
  • Ongoing research is expanding the role of EBRT in treating prostate cancer.